Expression of SH2D2A in T-cells is regulated both at the transcriptional and translational level

Molecular Immunology

Volumn 45, Issue 8, 2008, Pages 2380-2390

  Kolltveit, Kristin Melkevik ^a   Granum, Stine ^a   Aasheim, Hans Christian ^b   Forsbring, Monika ^a   Sundvold Gjerstad, Vibeke ^a   Dai, Ke Zheng ^c   Molberg, Øyvind ^c   Schjetne, Karoline W ^c   Bogen, Bjarne ^c   Shapiro, Virginia S ^d   Johansen, Finn Eirik ^c   Schenck, Karl ^a   Spurkland, Anne ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adapter protein; cAMP; Gene expression regulation; T cell activation

Indexed keywords

CARRIER PROTEIN; CYCLIC AMP; PROTEIN SH2D2A; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA TRANSLATION; T LYMPHOCYTE; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOPLASM; GENE EXPRESSION REGULATION; HUMANS; ISOQUINOLINES; MODELS, IMMUNOLOGICAL; PROTEIN BIOSYNTHESIS; RECEPTORS, ANTIGEN, T-CELL; RNA TRANSPORT; RNA, MESSENGER; SIGNAL TRANSDUCTION; SULFONAMIDES; TRANSCRIPTION, GENETIC;

EID: 40149103457     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.11.005     Document Type: Article

References (60)

1. Aandahl, E.M., Moretto, W.J., Haslett, P.A., Vang, T., Bryn, T., Tasken, K., Nixon, D.F., 2002. Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J. Immunol. 169, 802-808.
2. Anderson, P., Phillips, K., Stoecklin, G.,Kedersha, N., 2004. Post-transcriptional regulation of proinflammatory proteins. J. Leukoc. Biol. 76, 42-47.
3. Baker, K.E., Coller, J., 2006. The many routes to regulating mRNA translation. Genome Biol. 7, 332.
4. Browne, G.J., Proud, C.G., 2002. Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269, 5360-5368.
5. Carey, M., Smale, S.T., 2000. Modes of regulating mRNA abundance. In: Carey, M., Smale, S.T. (Eds.), Transcriptional Regulation in Eukaryotes. Concepts, Strategies and Techniques. Cold Spring Harbor Laboratory Press, NewYork, pp. 65-96.
6. Carrera, A.C., Rodriguez-Borlado, L., Martinez-Alonso, C., Merida, I., 1994. T cell receptor-associated alpha-phosphatidylinositol 3-kinase becomes activated by T cell receptor cross-linking and requires pp56lck. J. Biol. Chem. 269, 19435-19440.
7. Cham, C.M., Xu, H., O'Keefe, J.P., Rivas, F.V., Zagouras, P., Gajewski, T.F., 2003. Gene array and protein expression profiles suggest posttranscriptional regulation during CD8+ T cell differentiation. J. Biol. Chem. 278, 17044-17052.
8. Choi, Y.B., Kim, C.K., Yun, Y., 1999. Lad, an adapter protein interacting with the SH2 domain of p56lck, is required for T cell activation. J. Immunol. 163, 5242-5249.
9. Chomczynski, P., Sacchi, N., 1987. Single-step method ofRNAisolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
10. Dai, K.Z., Harbo, H.F., Celius, E.G., Oturai, A., Sorensen, P.S., Ryder, L.P., Datta, P., Svejgaard, A., Hillert, J., Fredrikson, S., Sandberg-Wollheim, M., Laaksonen, M., Myhr, K.M., Nyland, H., Vartdal, F., Spurkland, A., 2001. The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun. 2, 263-268.
11. Dai, K.Z., Johansen, F.E., Kolltveit, K.M., Aasheim, H.C., Dembic, Z., Vartdal, F., Spurkland, A., 2004. Transcriptional activation of the SH2D2A gene is dependent on a cyclic adenosine 5-monophosphate-responsive element in the proximal SH2D2A promoter. J. Immunol. 172, 6144-6151.
12. Dai, K.Z.,Vergnaud, G., Ando, A., Inoko, H., Spurkland, A., 2000. The SH2D2A gene encoding the T cell specific adapter protein (TSAd) is localized centromeric to the CD1 gene cluster on chromosome 1. Immunogenetics 51, 179-185.
13. Dailey, M.O., Schreurs, J., Schulman, H., 1988. Hormone receptors on cloned T lymphocytes. Increased responsiveness to histamine, prostaglandins, and beta-adrenergic agents as a late stage event in T cell activation. J. Immunol. 140, 2931-2936.
14. Diggle, T.A., Redpath, N.T., Heesom, K.J., Denton, R.M., 1998. Regulation of protein-synthesis elongation-factor-2 kinase by cAMP in adipocytes. Biochem. J. 336 (Pt 3), 525-529.
15. Drappa, J., Kamen, L.A., Chan, E., Georgiev, M., Ashany, D., Marti, F., King, P.D., 2003. Impaired T cell death and lupus-like autoimmunity in T cellspecific adapter protein-deficient mice. J. Exp. Med. 198, 809-821.
16. Dumitru, C.D., Ceci, J.D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J.H., Patriotis, C., Jenkins, N.A., Copeland, N.G., Kollias, G., Tsichlis, P.N., 2000. TNF-alpha induction by LPS is regulated posttranscriptionally via a pl2/ERK-dependent pathway. Cell 103, 1071-1083.
17. Fogel-Petrovic, M., Long, J.A., Knight, D.A., Thompson, P.J., Upham, J.W., 2004. Activated human dendritic cells express inducible cyclo-oxygenase and synthesize prostaglandin E2 but not prostaglandin D2. Immunol. Cell Biol. 82, 47-54.
18. Garcia-Sanz, J.A., Mikulits, W., Livingstone, A., Lefkovits, I., Mullner, E.W., 1998. Translational control: a general mechanism for gene regulation during T cell activation. FASEB J. 12, 299-306.
19. Gebauer, F., Hentze, M.W., 2004. Molecular mechanisms of translational control. Nat. Rev. Mol. Cell Biol. 5, 827-835.
20. Granum, S., Sundvold-Gjerstad, V., Dai, K.Z., Kolltveit, K.M., Hildebrand, K., Huitfeldt, H.S., Lea, T., Spurkland, A., 2006. Structure function analysis of SH2D2A isoforms expressed in T cells reveals a crucial role for the proline rich region encoded by SH2D2A exon 7. BMC Immunol. 7, 15.
21. Gutzkow, K.B., Lahne, H.U., Naderi, S., Torgersen, K.M., Skalhegg, B., Koketsu, M., Uehara, Y., Blomhoff, H.K., 2003. Cyclic AMP inhibits translation of cyclin D3 in T lymphocytes at the level of elongation by inducing eEF2-phosphorylation. Cell Signal. 15, 871-881.
22. Hovland, R., Eikhom, T.S., Proud, C.G., Cressey, L.I., Lanotte, M., Doskeland, S.O., Houge, G., 1999. cAMP inhibits translation by inducing Ca2+/calmodulin-independent elongation factor 2 kinase activity in IPC-81 cells. FEBS Lett. 444, 97-101.
23. Huang, S., Apasov, S.,Koshiba, M., Sitkovsky, M., 1997. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90, 1600-1610.
24. Ishii, S., Kihara, Y., Shimizu, T., 2005. Identification of T cell death-associated gene 8 (TDAG8) as a novel acid sensing G-protein-coupled receptor. J. Biol. Chem. 280, 9083-9087.
25. Johansson, C.C., Yndestad, A., Enserink, J.M., Ree, A.H., Aukrust, P., Tasken, K., 2004. The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3′,5′-monophosphate pathway in various cell types. Endocrinology 145, 5177-5184.
26. Kane, L.P.,Weiss, A., 2003. The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol. Rev. 192, 7-20.
27. Kennedy, M.S., Stobo, J.D., Goldyne, M.E., 1980. In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells. Prostaglandins 20, 135-145.
28. Kleijn, M., Proud, C.G., 2002. The regulation of protein synthesis and translation factors by CD3 and CD28 in human primary T lymphocytes. BMC Biochem. 3, 11.
29. Kuersten, S., Goodwin, E.B., 2003. The power of the 3′ UTR: translational control and development. Nat. Rev. Genet. 4, 626-637.
30. Kvanta, A., Gerwins, P., Jondal, M., Fredholm, B.B., 1990. Stimulation of Tcells with OKT3 antibodies increases forskolin binding and cyclic AMP accumulation. Cell Signal. 2, 461-470.
31. Ledbetter, J.A., Parsons, M., Martin, P.J., Hansen, J.A., Rabinovitch, P.S., June, C.H., 1986. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J. Immunol. 137, 3299-3305.
32. Lochner, A., Moolman, J.A., 2006. The many faces of H89: a review. Cardiovasc. Drug Rev. 24, 261-274.
33. Mao, X., Green, J.M., Safer, B., Lindsten, T., Frederickson, R.M., Miyamoto, S., Sonenberg, N., Thompson, C.B., 1992. Regulation of translation initiation factor gene expression during human T cell activation. J. Biol. Chem. 267, 20444-20450.
34. Marti, F., Garcia, G.G., Lapinski, P.E., MacGregor, J.N., King, P.D., 2006. Essential role of the T cell-specific adapter protein in the activation of LCK in peripheral T cells. J. Exp. Med. 203, 281-287.
35. Marti, F., Post, N.H., Chan, E., King, P.D., 2001. A transcription function for the T cell-specific adapter (TSAd) protein in T cells: critical role of the TSAd Src homology 2 domain. J. Exp. Med. 193, 1425-1430.
36. Mary, D., Aussel, C., Ferrua, B., Fehlmann, M., 1987. Regulation of interleukin 2 synthesis by cAMP in human T cells. J. Immunol. 139, 1179-1184.
37. Mayr, B., Montminy, M., 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2, 599-609.
38. Nejad, S., Bryceson, Y., Dissen, E., Sundvold-Gjerstad, V., Naper, C., Rolstad, B., Spurkland, A., Vaage, J.T., 2004. cDNA cloning of a rat orthologue of SH2D2A encoding T-cell-specific adaptor protein (TSAd): expression in T and NK cells. Immunogenetics 56, 338-342
39. Park, D., Choi, Y.B., Han, M.K., Kim, U.H., Shin, J., Yun, Y., 2001. Adaptor protein Lad relays PDGF signal to Grb2 in lung cells: a tissue-specific PDGF signal transduction. Biochem. Biophys. Res. Commun. 284, 275-281.
40. Perchonock, C.E., Pajerowski, A.G., Nguyen, C., Shapiro, M.J., Shapiro, V.S., 2007. The related adaptors, adaptor in lymphocytes of unknown function X and Rlk/Itk-binding protein, have nonredundant functions in lymphocytes. J. Immunol. 179, 1768-1775.
41. Prasanth, K.V., Prasanth, S.G., Xuan, Z., Hearn, S., Freier, S.M., Bennett, C.F., Zhang, M.Q., Spector, D.L., 2005. Regulating gene expression throughRNA nuclear retention. Cell 123, 249-263.
42. Rajagopal, K., Sommers, C.L., Decker, D.C., Mitchell, E.O., Korthauer, U., Sperling, A.I., Kozak, C.A., Love, P.E., Bluestone, J.A., 1999. RIBP, a novel Rlk/Txk- and itk-binding adaptor protein that regulates T cell activation. J. Exp. Med. 190, 1657-1668.
43. Rasmussen, A.M., Smeland, E.B., Erikstein, B.K., Caignault, L., Funderud, S., 1992. A new method for detachment of Dynabeads from positively selected B lymphocytes. J. Immunol. Methods 146, 195-202.
44. Saito, T., Yamasaki, S., 2003. Negative feedback of T cell activation through inhibitory adapters and costimulatory receptors. Immunol. Rev. 192, 143-160.
45. Scheu, S., Stetson, D.B., Reinhardt, R.L., Leber, J.H., Mohrs, M., Locksley, R.M., 2006. Activation of the integrated stress response during T helper cell differentiation. Nat. Immunol. 7, 644-651.
46. Scott, P.H., Lawrence Jr., J.C., 1998. Attenuation of mammalian target of rapamycin activity by increased cAMP in 3T3-L1 adipocytes. J. Biol. Chem. 273, 34496-34501.
47. Smerdel, A., Dai, K.Z., Lorentzen, A.R., Flato, B., Maslinski, S., Thorsby, E., Forre, O.O., Spurkland, A., 2004. Genetic association between juvenile rheumatoid arthritis and polymorphism in the SH2D2A gene. Genes Immun. 5, 310-312.
48. Spurkland, A., Brinchmann, J.E., Markussen, G., Pedeutour, F., Munthe, E., Lea, T., Vartdal, F., Aasheim, H.C., 1998. Molecular cloning of a T cellspecific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites. J. Biol. Chem. 273, 4539-4546.
49. Sun,W., Kesavan, K., Schaefer, B.C., Garrington, T.P.,Ware, M., Johnson, N.L., Gelfand, E.W., Johnson, G.L., 2001. MEKK2 associates with the adapte rprotein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. J. Biol. Chem. 276, 5093-5100.
50. Sundvold,V., Torgersen, K.M., Post, N.H., Marti, F., King, P.D., Rottingen, J.A., Spurkland, A., Lea, T., 2000. T cell-specific adapter protein inhibits T cell activation by modulating Lck activity. J. Immunol. 165, 2927-2931.
51. Sundvold-Gjerstad, V., Granum, S., Mustelin, T., Andersen, T.C., Berge, T., Shapiro, M.J., Shapiro, V.S., Spurkland, A., Lea, T., 2005. The C terminus of T cell-specific adapter protein (TSAd) is necessary for TSAd-mediated inhibition of Lck activity. Eur. J. Immunol. 35, 1612-1620.
52. Swanson, B.J., Murakami, M., Mitchell, T.C., Kappler, J., Marrack, P., 2002. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity 17, 605-615.
53. Tasken, K., Stokka, A.J., 2006. The molecular machinery for cAMP-dependent immunomodulation in T-cells. Biochem. Soc. Trans. 34, 476-479.
54. Togni, M., Lindquist, J., Gerber, A., Kolsch, U., Hamm-Baarke, A., Kliche, S., Schraven, B., 2004. The role of adaptor proteins in lymphocyte activation. Mol. Immunol. 41, 615-630.
55. Torgersen, K.M.,Vang, T., Abrahamsen, H.,Yaqub, S., Tasken, K., 2002. Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell Signal. 14, 1-9.
56. Vendetti, S., Riccomi, A., Sacchi, A., Gatta, L., Pioli, C., De Magistris, M.T., 2002. Cyclic adenosine 5′-monophosphate and calcium induce CD152 (CTLA-4) up-regulation in resting CD4+ T lymphocytes. J. Immunol. 169, 6231-6235.
57. Walzer, T., Marcais, A., Saltel, F., Bella, C., Jurdic, P., Marvel, J., 2003. Cutting edge: immediate RANTES secretion by resting memory CD8 T cells following antigenic stimulation. J. Immunol. 170, 1615-1619.
58. Welsh, G.I., Miyamoto, S., Price, N.T., Safer, B., Proud, C.G., 1996. Tcell activation leads to rapid stimulation of translation initiation factor eIF2B and inactivation of glycogen synthase kinase-3. J. Biol. Chem. 271, 11410-11413.
59. Wu, L.W., Mayo, L.D., Dunbar, J.D., Kessler, K.M., Ozes, O.N., Warren, R.S., Donner, D.B., 2000. VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor. J. Biol. Chem. 275, 6059-6062.
60. Zeddou, M., Greimers, R., de, V.N., Nayjib, B., Tasken, K., Boniver, J., Moutschen, M., Rahmouni, S., 2005. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway. Biochem. Pharmacol. 70, 714-724.